DrugInfoSys

Pyridostigmine (Br)

Drug #636

Pyridostigmine (Br) is a quaternary ammonium cholinesterase inhibitor. Pyridostigmine (Br) is a muscular stimulant. It has longer duration of action than that of neostigmine. Pyridostigmine (Br) is used in the chronic management of myasthenia gravis.Pyridostigmine (Br) is also used to reverse the actions of nondepolarizing neuromuscular blockers after surgery. Pyridostigmine was approved by the FDA in 1955.

Primary Characteristics

It is of Synthetic origin and belongs to Quaternary Ammonium.

It belongs to Cholinestrase inhibitor pharmacological group on the basis of mechanism of action and also classified in Cholinergic Agonist pharmacological group. It is also classified under Antidotes .

Molecular Weight: 261.1 · pKa: strongly basic · Solubility in Water: > 1 in 1 · Solubility in Alcohol: > 1 in 1 · Non-proprietary name: Pyridostigmine (Br) · pH: 7.2 · Isotonic value: 4.13.

Molecular structure of Pyridostigmine (Br)

Pharmacokinetics

Absorption: Pyridostigmine (Br) has an oral bioavailability is 45.5% (±4.5%).

Distribution: Pyridostigmine (Br) has a volume of distribution is 0.53 - 1.8 l/kg. plasma protein binding is negligible.

Elimination: plasma half-life is 0.38 - 1.9 hr, renal excretion is 90%.

Advertisement

Indications

Pyridostigmine (Br) is primarily indicated in conditions like Myasthenia gravis, Paralytic ileus, Urinary retention, Urinary retention.

Contraindications

Pyridostigmine (Br) is contraindicated in conditions like Intestinal obstruction, Urinary obstruction.

Dosage

Pyridostigmine (Br)'s dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
3.5 mg/dose3.5 mg/doseEvery 2.4hIV,IM
60 – 180 mgPOIn Divided doses for Myasthenia Gravis
750 mg750 mgPOIn Divided doses for Myasthenia Gravis
Paediatric Dosage (20kg)
3 mg/kg3 mg/kgEvery 6hOral Adjust Dose as per response obtained
Neonatal Dosage (3kg)
2.187 mg/kg2.187 mg/kgEvery 6hOralInitial dose , then adjust according to response

Drug Interactions

Unknown15 interactions
9 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Pyridostigmine (Br) in overdosage may give rise to further complications which include Hallucinations , Disorientation , Anxiety , Epilepsy , Loss of consciousness.

The signs and symptoms that are produced after acute overdosage of Pyridostigmine (Br) are Dizziness, Salivation , Sweating , Abdominal pain, Bradycardia, Diarrhea, Depolarizing block.

Pyridostigmine (Br) is known to cause more or less tolerable side effects which are usually transient. These include SweatingX.

Warnings / Precautions

Pyridostigmine should be used with caution in patients with any pre-existing stomach disorders, kidney or urinary problems, ulcers, asthma, epilepsy, heart diseases, thyroid disorders or allergies especially to bromides or anticholinesterases. Notify the doctor if this medication appears to be losing its effect. In some cases, people become insensitive to the medication and it must be stopped for a brief period. It should be used only if clearly needed during pregnancy or lactation.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Tabs

Multi-Ingredient Combinations

Storage Conditions

Pyridostigmine (Br) should be stored Syrup. Tab.

Drug Classification

  1. 1.20Muscle relaxants and cholinesterase inhibitors

Manufacturers

Manufacturers of Pyridostigmine (Br) in Pakistan: